Paul S. Donnelly

Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

Peter J. Crouch, Lin W. Hung, Paul A. Adlard et al. · Proceedings of the National Academy of Sciences · 2009 · 263 citations · Full text

Neurodegenerative Diseases, Cognitive Decline, Alzheimer's Disease +15

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Craig S. Anderson, Yining Huang, Richard I. Lindley et al. · The Lancet · 2019 · 262 citations · Full text

Thrombosis, Hypertension, Cardiovascular Disease +13

Comparison of ⁶⁴Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and <i>in Vitro</i>/<i>in Vivo</i> Stability

Maggie Cooper, Kavitha Sunassee, Karen Shaw et al. · Bioconjugate Chemistry · 2012 · 208 citations · Full text

Engineering, Specific Activity, Immunology +23

Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Blaine R. Roberts, Nastasia K.-H. Lim, Erin J. McAllum et al. · Journal of Neuroscience · 2014 · 199 citations · Full text

Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide

Paul S. Donnelly, Aphrodite Caragounis, Tai Du et al. · Journal of Biological Chemistry · 2007 · 191 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +15